COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:30, il y a 1 année Inside Information / Other news releases Sensorion announces Pr. Natalie Loundon presenting at 2025 ASPO Annual Meeting on SENS-501 gene therapy for hearing loss in children with DFNB9, Audiogene trial details and Sensorion's focus on developing therapies for hearing loss disorders Gene Therapy Sensorion Hearing Loss Audiogene Trial Pr. Natalie Loundon
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:30, il y a 1 année Informations privilégiées / Autres communiqués Sensorion annonce la participation du Dr. Natalie Loundon à la réunion annuelle de la Société américaine d'oto-rhino-laryngologie pédiatrique pour présenter la thérapie génique SENS-501 pour la perte auditive Thérapie Génique Sensorion Perte Auditive Dr. Natalie Loundon ASPO
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:30, il y a 1 année Informations privilégiées / Autres communiqués SSCL obtient une extension de contrat de plus de 300M£ pour fournir des services essentiels au gouvernement britannique pendant trois années supplémentaires. Sopra Steria et SSCL renforcent leur position sur le marché britannique avec un nouvel accord de 3 ans Sopra Steria Extension De Contrat SSCL Services Essentiels Gouvernement Britannique
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:15, il y a 1 année Patria Genossenschaft acquires Baloise shares from Cevian Capital Patria Genossenschaft acquires 9.351% Baloise shares from Cevian Capital. Robert Schuchna steps down from election. Baloise simplifies merger with Helvetia Merger Helvetia Baloise Shares Patria Genossenschaft Cevian Capital
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:15, il y a 1 année Patria Genossenschaft acquires Baloise shares from Cevian Capital Patria Genossenschaft acquires 9.351% of Baloise shares from Cevian Capital. Extraordinary General Meeting on 23 May 2025 to vote on merger with Helvetia Merger Helvetia Baloise Shares Patria Genossenschaft Cevian Capital
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:15, il y a 1 année Acquisition or disposal of the issuer's own shares / Description of the buyback program Eurofins launches sixth buy-back programme of its own shares with plans to repurchase up to 4.5% of share capital. Programme starting on 25 April 2025 aims to hedge Long-Term Incentive plans and support other financial initiatives Share Capital Financial Services Buy-back Programme Eurofins ISIN FR0014000MR3
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:01, il y a 1 année PALFINGER aims for 2025 to be the second strongest financial year in the company's history PALFINGER AG aims for 2025 to be the second strongest financial year in the company's history, with positive order intake and global development Revenue Growth Financial Year Order Intake PALFINGER AG Global Development
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 1 année Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence Xlife Sciences AG publishes 2024 Annual Report highlighting strategic partnerships, technological milestones, and dual listing plans on SIX and LSE to enhance international market presence Strategic Partnerships Dual Listing Xlife Sciences AG 2024 Annual Report Technological Milestones
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 1 année Swiss Life publishes financial condition report – solvency remains strong Swiss Life publishes financial condition report with strong solvency position, exceeding strategic ambition range. Detailed information available at www.swisslife.com/results Swiss Life Swiss Life Group Financial Condition Report Solvency 2024 Annual Report
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 1 année EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
Publié le 18/05/2026 à 11:06, il y a 4 heures 42 minutes GUILLEMOT CORPORATION: Weekly report share buyback From May 11th to May 15th 2026
Publié le 18/05/2026 à 11:06, il y a 4 heures 42 minutes GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres du 11 mai 2026 au 15 mai 2026
Publié le 18/05/2026 à 08:30, il y a 7 heures 18 minutes Thales appoints Jérémie Papin Senior Executive Vice-President, Finance and Information Systems
Publié le 18/05/2026 à 08:30, il y a 7 heures 18 minutes Thales nomme Jérémie Papin Directeur général, Finance et Systèmes d’Information
Publié le 15/05/2026 à 15:08, il y a 3 jours Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Publié le 18/05/2026 à 14:37, il y a 1 heure 11 minutes Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
Publié le 18/05/2026 à 14:30, il y a 1 heure 18 minutes Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
Publié le 16/05/2026 à 01:15, il y a 2 jours 14 heures Findev Inc. Announces a New Member of the Board of Directors
Publié le 18/05/2026 à 15:37, il y a 11 minutes Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Publié le 18/05/2026 à 15:36, il y a 12 minutes Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc